OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2024
(3)
2023
(3)
2022
(2)
2021
(1)
2020
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Hejie Zhitong prescription promotes sleep and inhibits nociceptive transmission-associated neurotransmitter activity in a rodent migraine model.
Not available
S-EPMC7526328
|
biostudies-literature
Cite
TGF-β signaling in health, disease, and therapeutics.
Not available
S-EPMC10958066
|
biostudies-literature
Cite
Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq.
Not available
S-EPMC9375433
|
biostudies-literature
Cite
CXXC finger protein 1 (CFP1) bridges the reshaping of genomic H3K4me3 signature to the advancement of lung adenocarcinoma.
Not available
S-EPMC10514036
|
biostudies-literature
Cite
H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma.
Not available
S-EPMC10155324
|
biostudies-literature
Cite
Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma.
Not available
S-EPMC10809653
|
biostudies-literature
Cite
Outcomes and prognosis of non-small cell lung cancer patients who underwent curable surgery: a protocol for a real-world, retrospective, population-based and nationwide Chinese National Lung Cancer Cohort (CNLCC) study.
Not available
S-EPMC10410851
|
biostudies-literature
Cite
Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes.
Not available
S-EPMC8213753
|
biostudies-literature
Cite
PVR/TIGIT and PD-L1/PD-1 expression predicts survival and enlightens combined immunotherapy in lung squamous cell carcinoma.
Not available
S-EPMC9352965
|
biostudies-literature
Cite
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.
Not available
S-EPMC11405280
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets